---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-024074"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2023-05-25T23:59:59+00:00"
generated_at: "2026-06-14T15:28:47.835493+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences prices $16.5M registered direct offering of 3M shares at $5.50/share

## Summary
- Sold 3,000,000 shares at $5.50 each for gross proceeds of ~$16.5M; net proceeds ~$15.2M.
- Offering includes participation from current investors Dialectic Life Sciences, Hunt Family affiliates, and management.
- Proceeds to fund cytisinicline development for smoking cessation and for working capital.
- Expected to close on or about May 30, 2023; Lake Street Capital Markets as placement agent.

## SEC filing metadata
- accession: 0000950170-23-024074
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2023-05-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000095017023024074/0000950170-23-024074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000095017023024074/achv-20230525.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-024074
- JSON: https://secwatch.observer/filing/0000950170-23-024074.json
- Plain text: https://secwatch.observer/filing/0000950170-23-024074.txt

## Key facts
- Material Agreements
  ACHIEVE LIFE SCIENCES, INC. entered into Securities Purchase Agreement with certain purchasers valued at 3,000,000 shares at $5.50 per share, gross proceeds approximately $16.5 million (effective 2023-05-25).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain purchasers
  - Value: 3,000,000 shares at $5.50 per share, gross proceeds approximately $16.5 million
  - Effective: 2023-05-25
  source text: On May 25, 2023, Achieve Life Sciences, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain purchasers for the sale of 3,000,000 shares (the “Shares”) of the Company’s common stock at a price of $5.50 per share, for gross proceeds of approximately $16.5 million before deducting the placement fees and related offering expenses.
  evidence_url: https://www.sec.gov/Archives/edgar/data/949858/000095017023024074/0000950170-23-024074-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.